Search

Your search keyword '"L. Kaufman"' showing total 3,616 results

Search Constraints

Start Over You searched for: Author "L. Kaufman" Remove constraint Author: "L. Kaufman"
3,616 results on '"L. Kaufman"'

Search Results

1. Divergence of variant antibodies following SARS-CoV-2 booster vaccines in myeloma and impact of hybrid immunity

2. Specific symptom change associated with ecological momentary assessments of intrusive trauma memories

3. Quadruplet therapy for newly diagnosed myeloma: comparative analysis of sequential cohorts with triplet therapy lenalidomide, bortezomib and dexamethasone (RVd) versus daratumamab with RVD (DRVd) in transplant-eligible patients

4. Cryoablation and post-progression immune checkpoint inhibition in metastatic melanoma: a phase II trial

5. Daratumumab in transplant-eligible patients with newly diagnosed multiple myeloma: final analysis of clinically relevant subgroups in GRIFFIN

6. Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk

9. Child sexual abuse versus adult sexual assault: A review of psychological and neurobiological sequelae

10. Cytokine-armed oncolytic herpes simplex viruses: a game-changer in cancer immunotherapy?

11. Oncolytic herpes simplex virus expressing IL-2 controls glioblastoma growth and improves survival

13. Sex as a risk factor regarding presbyopia in the rhesus monkey.

14. Neuroimaging-based classification of PTSD using data-driven computational approaches: A multisite big data study from the ENIGMA-PGC PTSD consortium

15. Regulation of antigen-specific T cell infiltration and spatial architecture in multiple myeloma and premalignancy

16. Combination oncolytic virus, radiation therapy, and immune checkpoint inhibitor treatment in anti-PD-1-refractory cancer

17. The Systematic Application of Network Diagnostics to Monitor and Tackle Bullying and Victimization in Schools

21. The GABA and GABA-Receptor System in Inflammation, Anti-Tumor Immune Responses, and COVID-19

23. P937: PRECLINICAL DISCOVERY AND EARLY FINDINGS FROM THE PHASE 1, DOSE-ESCALATION STUDY OF WVT078, A BCMA-CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH R/R MULTIPLE MYELOMA

25. P934: DARATUMUMAB + LENALIDOMIDE, BORTEZOMIB, AND DEXAMETHASONE IN TRANSPLANT-ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA: A POST HOC ANALYSIS OF SUSTAINED MINIMAL RESIDUAL DISEASE NEGATIVITY FROM GRIFFIN

26. Depression Socialization in Early Adolescent Friendships: The Role of Baseline Depressive Symptoms and Autonomous Functioning

27. Clinical landscape of oncolytic virus research in 2020

28. Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery Committee

29. Defining current gaps in quality measures for cancer immunotherapy: consensus report from the Society for Immunotherapy of Cancer (SITC) 2019 Quality Summit

30. Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19

31. Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

32. Subcutaneous daratumumab in patients with relapsed or refractory multiple myeloma: Part 2 of the open-label, multicenter, dose-escalation phase 1b study (PAVO)

33. A comparison of methods to harmonize cortical thickness measurements across scanners and sites.

35. The Relationship of Attention-Deficit/Hyperactivity Disorder With Posttraumatic Stress Disorder

38. Designing Personalized Antigen-Specific Immunotherapies for Autoimmune Diseases—The Case for Using Ignored Target Cell Antigen Determinants

39. GABA Administration Ameliorates Sjogren’s Syndrome in Two Different Mouse Models

41. Cover

46. Part 1. Contexts

47. Introduction

48. List of Illustrations

Catalog

Books, media, physical & digital resources